Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.170
-0.060 (-4.88%)
At close: Mar 27, 2026, 4:00 PM EDT
1.160
-0.010 (-0.85%)
After-hours: Mar 27, 2026, 6:36 PM EDT

Pliant Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
45.4571.1963.2333.6951.67
Short-Term Investments
145.5284.54431.01297.5148.93
Cash & Short-Term Investments
190.94355.72494.25331.19200.6
Cash Growth
-46.32%-28.03%49.23%65.10%-27.56%
Accounts Receivable
---1.982
Other Receivables
---0.080.08
Total Trade Receivables
---2.072.08
Other Current Assets
5.56.5411.267.066.76
Total Current Assets
196.45362.26505.5340.31209.44
Net Property, Plant & Equipment
26.9132.774.789.9110.94
Other Long-Term Assets
1.871.921.870.390.84
Total Assets
225.23396.95512.15350.61221.22
Accounts Payable
0.485.964.531.582.97
Accrued Expenses
14.4426.7222.6819.8811.99
Current Portion of Leases
1.450.541.322.461.87
Total Current Liabilities
16.3733.2228.5223.9116.83
Long-Term Debt
-30.2110.059.93-
Long-Term Leases
27.6629.44-3.435.33
Total Long-Term Liabilities
27.6659.6510.0513.365.33
Total Liabilities
44.0292.8738.5837.2722.16
Common Stock
0.010.010.010.010
Additional Paid-in Capital
1,0411,014972.97653.71414.35
Accumulated Other Comprehensive Income
-0.020.320.35-1.96-0.2
Retained Earnings
-859.4-710.05-499.75-338.41-215.09
Shareholders' Equity
181.21304.08473.58313.34199.06
Total Liabilities & Equity
225.23396.95512.15350.61221.22
Total Debt
29.1160.1911.3715.827.19
Net Cash (Debt)
161.84295.53482.87315.37193.4
Net Cash Growth
-45.24%-38.80%53.11%63.07%-30.15%
Net Cash Per Share
2.644.888.227.515.39
Book Value
181.21304.08473.58313.34199.06
Book Value Per Share
2.955.028.077.465.55
Tangible Book Value
181.21304.08473.58313.34199.06
Tangible Book Value Per Share
2.955.028.077.465.55
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q